Surfactant therapy and spontaneous diuresis

Area of Science:

• Neonatal Medicine
• Pulmonology
• Nephrology

Background:

• Hyaline membrane disease (HMD) is a common respiratory distress in preterm infants.
• Surfactant replacement therapy improves respiratory outcomes in HMD.
• The impact of surfactant therapy on renal function and diuresis in neonates is not fully understood.

Purpose of the Study:

• To prospectively evaluate the effect of artificial surfactant therapy on renal function and spontaneous diuresis in infants with HMD.
• To compare renal parameters between infants receiving surfactant and those receiving placebo.

Main Methods:

• A double-blind, controlled study involving 19 infants with HMD.
• Infants were randomized to receive either artificial surfactant or placebo (0.9% saline).
• Renal function was assessed by spontaneous diuresis, glomerular filtration rate (endogenous creatinine clearance), fractional excretion of sodium, and sodium balance.

Main Results:

• No significant difference in the onset of spontaneous diuresis or glomerular filtration rate between surfactant and placebo groups.
• Fractional excretion of sodium was significantly higher in the placebo group at 24 and 36 hours.
• Infants in the placebo group exhibited a greater negative sodium balance.
• Ventilatory status significantly improved in the surfactant group, indicated by improved alveolar/arterial oxygen pressure ratio and lower mean airway pressure.

Conclusions:

• Artificial surfactant therapy can improve ventilatory status in infants with HMD without necessitating diuresis.
• The regulation of diuresis in neonates is complex and influenced by multiple factors beyond surfactant therapy.
• Further research is needed to elucidate the mechanisms governing diuresis in this population.